746 related articles for article (PubMed ID: 21706294)
1. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
Julkunen H; Ekblom-Kullberg S; Miettinen A
Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
[TBL] [Abstract][Full Text] [Related]
2. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
3. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
Emad G; Al-Barshomy SM
Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
[TBL] [Abstract][Full Text] [Related]
4. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
[TBL] [Abstract][Full Text] [Related]
5. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
6. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
Pradhan V; Mahant G; Rajadhyaksha A; Surve P; Rajendran V; Patwardhan M; Nadkarni A; Dighe S; Ghosh K
Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892
[TBL] [Abstract][Full Text] [Related]
7. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
8. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
Jaekell HP; Trabandt A; Grobe N; Werle E
Lupus; 2006; 15(6):335-45. PubMed ID: 16830879
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
[TBL] [Abstract][Full Text] [Related]
10. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.
Picard C; Lega JC; Ranchin B; Cochat P; Cabrera N; Fabien N; Belot A
Pediatr Nephrol; 2017 Sep; 32(9):1537-1545. PubMed ID: 28343355
[TBL] [Abstract][Full Text] [Related]
11. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M
Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587
[TBL] [Abstract][Full Text] [Related]
12. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
13. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
Kim AHJ; Strand V; Sen DP; Fu Q; Mathis NL; Schmidt MJ; Bruchas RR; Staten NR; Olson PK; Stiening CM; Atkinson JP
Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950
[TBL] [Abstract][Full Text] [Related]
14. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
[TBL] [Abstract][Full Text] [Related]
15. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
Mok CC; Ho LY; Leung HW; Wong LG
Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
Matrat A; Veysseyre-Balter C; Trolliet P; Villar E; Dijoud F; Bienvenu J; Fabien N
Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis.
Heidenreich U; Mayer G; Herold M; Klotz W; Stempfl Al-Jazrawi K; Lhotta K
Lupus; 2009 Dec; 18(14):1276-80. PubMed ID: 19854810
[TBL] [Abstract][Full Text] [Related]
18. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
Kianmehr N; Khoshmirsafa M; Shekarabi M; Falak R; Haghighi A; Masoodian M; Seif F; Omidi F; Shirani F; Dadfar N
J Immunoassay Immunochem; 2021 Jul; 42(4):406-423. PubMed ID: 33788670
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
20. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
